Adaptimmune Therapeutics PLC Sponsored ADR SEC filings and other documents
Data partner
Description
Reported date
Form
2025
Q2 2025
Aug 13, 2025
Quarterly report10-Q
Earnings release8-K
Q1 2025
May 13, 2025
Transcript
Quarterly report10-Q
Earnings release8-K
2024
Q4 2024
Mar 20, 2025
Transcript
Annual report10-K
Earnings release8-K
Q3 2024
Nov 13, 2024
Quarterly report10-Q
Earnings release8-K
Q2 2024
Aug 12, 2024
Quarterly report10-Q
Earnings release8-K
FDA Announcement
Aug 02, 2024
Slides
Press release
Collaboration
May 31, 2024
Press release
Q1 2024
May 15, 2024
Quarterly report10-Q
Earnings release8-K
2023
Q4 2023
Mar 06, 2024
Annual report10-K
Earnings release8-K
Q3 2023
Nov 08, 2023
Quarterly report10-Q
Earnings release8-K
Q2 2023
Aug 09, 2023
Quarterly report10-Q
Earnings release8-K
Q1 2023
May 12, 2023
Quarterly report10-Q
Earnings release8-K
2022
Q4 2022
Mar 06, 2023
Annual report10-K
Earnings release8-K
Q3 2022
Nov 08, 2022
Quarterly report10-Q
Earnings release8-K
Q2 2022
Aug 04, 2022
Quarterly report10-Q
Earnings release8-K
Q1 2022
May 09, 2022
Quarterly report10-Q
Earnings release8-K
2021
Q4 2021
Mar 14, 2022
Annual report10-K
Earnings release8-K
Q3 2021
Nov 04, 2021
Quarterly report10-Q
Earnings release8-K
Q2 2021
Aug 09, 2021
Quarterly report10-Q
Earnings release8-K
Q1 2021
May 06, 2021
Quarterly report10-Q
Earnings release8-K
2020
Q4 2020
Feb 25, 2021
Annual report10-K
2019
Q4 2019
Feb 27, 2020
Annual report10-K
2018
Q4 2018
Feb 27, 2019
Annual report10-K
2017
Q4 2017
Mar 15, 2018
Annual report10-K
2016
Q4 2016
Mar 13, 2017
Annual report10-K